Biodistribution and radiation dosimetry of the novel ¹⁸F-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.